Ganesh Venkatraman

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Journal of cellular physiology

Metabolites

Oncogene

Cancers

Sri Ramachandra University

Cancer Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sri Ramachandra University

India

Professor :: Human Genetics

Education History

Cancer Institute

India

PHD :: Biochemistry

Publications

Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology 239 (4) (2024)
Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology (2024)
Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology 239 (4) (2024)
Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology 239 (4) (2024)
Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence. Metabolites 13 (4) (2023)
Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence. Metabolites 13 (4) (2023)
Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence. Metabolites 13 (4) (2023)
Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence. Metabolites 13 (4) (2023)
Vishnupriya Kanakaveti, Sakthivel Ramasamy, Rahul Kanumuri, Vaishnavi Balasubramanian, Roshni Saravanan, Inemai Ezhil, Ravishankar Pitani, Ganesh Venkatraman, Suresh Kumar Rayala, M Michael Gromiha
Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer. Cancers 14 (21) (2022)
Roshni Saravanan, Vaishnavi Balasubramanian, Srikanth Swamy Swaroop Balamurugan, Inemai Ezhil, Zeba Afnaan, Jisha John, Sandhya Sundaram, Shanmugasundaram Gouthaman, Suresh B Pakala, Suresh Kumar Rayala, Ganesh Venkatraman
Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer. Journal of cellular physiology 237 (11) (2022)
Rahul Kanumuri, Aruna Kumar Chelluboyina, Jayashree Biswal, Ravichandran Vignesh, Jaishree Pandian, Akkanapally Venu, B Vaishnavi, D J Leena, Jeyakanthan Jeyaraman, Kumaresan Ganesan, Gopala Krishna Aradhyam, Ganesh Venkatraman, Suresh Kumar Rayala
Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1-RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic function. Oncogene 40 (34) (2021)
Geraldine Sandana Mala John, Veena Kumari Vuttaradhi, Satoru Takeuchi, Ravi Shankar Pitani, Ganesh Venkatraman, Suresh Kumar Rayala
Facile synthesis and nanoscale features of a nanostructured nordihydroguaiaretic acid analog for therapeutic applications. Journal of nanobiotechnology 18 (1) (2020)
Karthika P Padmavathy, Veena Kumari Vuttaradhi, Akkanapally Venu, Lawrence D'Cruze, Roshni Saravanan, Ravishankar Pitani, Krishnamurthy Ganesh, Himavani Pacharla, Suresh Kumar Rayala, D Prathiba, Ganesh Venkatraman
Clinical Evaluation of Proline, Glutamic acid, and Leucine-Rich Protein 1 Expression in Astrocytomas and Correlations with the Proliferation Marker Ki-67. Journal of molecular neuroscience : MN 71 (4) (2020)
Swarnalatha Beesetti, Rohan P Surabhi, Suresh Kumar Rayala, Ganesh Venkatraman
Mechanics of PAK1-A new molecular player in the arena of skin cancer. Journal of cellular physiology 234 (1) (2018)
Shilpa Tentu, Kumarswamyreddy Nandarapu, Prakash Muthuraj, Kesavan Venkitasamy, Ganesh Venkatraman, Suresh K Rayala
DHQZ-17, a potent inhibitor of the transcription factor HNF4A, suppresses tumorigenicity of head and neck squamous cell carcinoma in vivo. Journal of cellular physiology 233 (3) (2017)

Ganesh Venkatraman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ganesh Venkatraman